View More Recent Stories
-
Coya Therapeutics (COYA) Announces that Results from a Double-Blind Placebo-Controlled Study in Alzheimer’s Disease will be presented on October 29,
-
Coya Therapeutics (COYA) Files for New U.S. Patents for COYA 301 in Combination with GLP-1 Receptor
-
Coya Therapeutics (COYA) Expands Sponsored Research Collaboration with Houston Methodist Research Institute
-
Coya Therapeutics (COYA) Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in Neurology
